Cordlife Medical Philippines Inc (“Cordlife” or the
“Company”), a fully owned subsidiary of Cordlife Group Limited, a Singapore
Exchange mainboard listed consumer healthcare company catering to the mother
and child segment, announced the opening of their newly upgraded stem cell
processing and cryopreservation facility at UP-Ayalaland Technohub, Quezon
City. This expansion came less than 5 years from the opening of its facility in
the country and was mainly driven by the growing number of parents who
recognize the value of banking their baby’s stem cells in the country.
 |
| Delamar: Host |
The event launch held at Crowne Plaza in Ortigas on
Nov. 18, 2014 was hosted by popular DJ Delamar Arias
“With over 13 years of experience in the industry and as a mainboard-listed healthcare company on the Singapore Exchange, we are in the position to provide long-haul high quality stem cell banking service to parents in the Philippines,” says Jeremy Yee.
Also in attendance to underscore Cordlife’s
commitment to Filipino parents and their children were Cordlife Group CEO
Jeremy Yee, Cordlife Philippines Medical Director Dr. Arvin Faundo, and
Cordlife Philippines Director Michael Arnonobal.
Cordlife Philippines Medical Director Dr. Arvin Faundo
Cordlife Philippines Director Michael Arnonobal
The event highlighted the five essentials of mother
and child that Cordlife addresses through services. These essentials are security,
expertise, investment, bond, and value for life.
With the newly upgraded stem cell facility that can
accommodate up to 30,000 cord blood and cord lining units, more parents can
enjoy a sense of security when they bank their baby’s stem cells at Cordlife’s
state-of-the-art processing and cryopreservation laboratory. Parents who banked
with Cordlife can have peace of mind knowing that their baby’s stem cells are
kept in a highly secure laboratory that was built to withstand earthquakes of
up to magnitude 8, and ward off fire with its fire-retardant walls.
Furthermore, the vapour-phased liquid nitrogen cryogenic tanks used to preserve
the cord blood and cord lining samples are not dependent on electricity, making
them 100% safe and reliable in case of power outages.
Cordlife’s expertise in the stem cell banking arena,
is proven not only by being the largest network of cord blood banks in Asia,
but also the number of cord blood releases for stem cell transplant and their
adherence to the stringent global standards of AABB (formerly known as American
Association of Blood Banks). Cordlife Philippines is also the country’s first
and only ISO 9001:2008 and Department of Health-registered cord blood and cord
lining bank.
In addition to cord blood banking, Cordlife
Philippines also offers cord tissue banking service, launched last year. “While
cord blood is a rich source of hematopoietic stem cells used to treat blood
disorders, cord tissue is a rich source
of mesenchymal and epithelial stem cells, both of which are now under extensive
clinical study for regenerative medicine and a host of other applications such
as stroke, myocardial infarction and diabetes treatment,” according to Dr.
Arvin Faundo. “Stem cell therapy is indeed one of the brightest spots in the
future of medicine, and families can start investing on this future today with
Cordlife,” he adds.
Cordlife emphasized once more their commitment to
provide more value for life by being a steadfast partner to parents who wish to
bank their baby’s stem cells because of their proven ability to treat Leukemia,
Thallasemia and other types of cancers2. “I actively tried to develop our
parenting IQ, from how to change a diaper to knowing the many diseases that
could threaten my baby’s future. I still remember the sense of relief having
found out that we could provide him biological insurance through stem cell
banking,” saying Lara Quigaman.
By storing the blood and lining of their baby’s
umbilical cord, the first connection between mom and child, Cordlife helps
preserve this precious bond. Partnerships are forged with trusted hospitals and
research institutes like Duke Medicine research, adding more value to this
special mother and child bond.
All these essentials are available to parents as a
practical investment for their child’s health. “To help the most number of
Filipino families access this important service, Cordlife offers cord blood/cord
lining banking for as low as P8,000 per year, and offers flexible payment
schemes that are within reach of most families,” says Michael Arnonobal.
- The End –
ABOUT CORDLIFE MEDICAL PHILIPPINES INC
Cordlife Philippines was officially launched in February
2010 as Philippines’ first and only cord blood processing and cryopreservation
facility to better serve the cord blood banking needs of the local market.
Registered with the Department of Health, the ISO-certified facility was built
in accordance to global gold standards such as the American Association of
Blood Banks to give local families peace of mind. In 2013, the Company launched
the country’s first and only cord lining banking service, using CellOptima™, a
patented technology invented in Singapore that can isolate and expand two types
of stem cells from the umbilical cord lining. Cordlife’s 365-day facility is
equipped with the world’s most advanced fully automated cord blood processing
system, SEPAX-2® and has a storage capacity for 30,000 cord blood units.
Cordlife Philippines is a subsidiary of Cordlife Group Limited, a mainboard
company listed on the Singapore Exchange.
ABOUT CORDLIFE GROUP LIMITED (Bloomberg stock code:
CLGL)
Incorporated in May 2001, Cordlife Group Limited
(“Cordlife”, and together with its subsidiaries, the “Group”), is a consumer
healthcare company catering to the mother and child segment and a leading cord
blood and umbilical cord lining banking services provider. Amongst the first
private cord blood banks in Asia, Cordlife has established a dominant market
leader position in Singapore . Today, it has the larger market share of the
only two private cord blood banks in Singapore. In Hong Kong, it is amongst the
three market leaders for private cord blood banks. Cordlife completed the
acquisition of the cord blood and umbilical cord lining banking businesses and
assets in India, the Philippines and Indonesia from Australia-listed Life
Corporation Limited (formerly known as Cordlife Limited) in June 2013.
Cordlife, through its collaborative relationships or
arrangements with major private hospitals and clinics such as Thomson Medical
and Parkway East Hospital, has continued to increase public awareness of its
cord blood banking services in Singapore. Overseas, the Group has a 10% direct
stake in China Cord Blood Corporation – a top cord blood bank operator in China
holding majority shares in the Beijing, Guangdong and Zhejiang Cord Blood
Banks, and an approximately 24% share in Shandong Cord Blood Bank. In October
2013, Cordlife also acquired a 19.92% stake, which was subsequently increased
to approximately 31.81% in December 2013, in StemLife Berhad. StemLife Berhad
is a fully licensed cord blood banking facility with the Ministry of Health
Malaysia currently listed on the ACE Market of Bursa Malaysia.
Cordlife has been accredited since 2005 by AABB
(formerly known as the American Association of Blood Banks), an association
involved in the field of transfusion medicine and cellular therapies. The Group
is one of the first private cord blood banks in Singapore and amongst the first
in Hong Kong to have released cord blood units for transplants and other
therapeutic use. In Singapore, Cordlife was the first private cord blood bank
to release cord blood units for the treatment of cerebral palsy.
Cordlife’s track record has won the Group many
accolades and awards, including: Best Medical Service Award 2010 by Capital CEO
Supreme Brand Awards; Top Pregnant/Baby Products Award 2011 by Pregnancy
Magazine; Outstanding Financial Strength Cord Blood Bank 2012 by Quamnet
Outstanding Enterprise Awards; Most Popular Brand Award 2010 – The Most Popular
Cord Blood Bank by TVB Weekly; U-Choice Lifestyle Brand Award 2010 by Metroinfo
FM99.7; Baby & Kid Brands Awards year 2013, “My Favourite Cord Blood Bank”
by Hong Kong Economic Times; and Baby Kingdom Top 10 Family Brand Award 2012 .
In October 2012, Cordlife was awarded the prestigious SIAS Investors’ Choice
Awards as runner-up in the “Most Transparent Company Award 2012” New Issues
Category. In August 2013, we were presented with Merit Award for the Singapore
Corporate Awards 2013, “Best Investor Relations Award”. In November 2013,
Cordlife was named the “Most Transparent Company 2013” in the Retail &
Household Goods Category and Mainboard Small Caps Category at the 14th SIAS
Investors’ Choice Awards.
No comments :
Post a Comment